sibrafiban

Xubix^™ Cardiology A 'superaspirin' GP IIb/IIIa receptor antagonist used to prevent post coronary-angioplasty coagulation

Mentioned in ?

super aspirin
SYMPHONY
Xubix

References in periodicals archive ?

Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes.

Elementos para la valoracion y el uso practico de los ensayos clinicos: parte I: estructura basica y terminologia usual

The oral glycoprotein inhibitor sibrafiban is no better than aspirin in secondary prevention of major ischemic events, even though it is the more potent inhibitor of platelet aggregation, reported Dr.

Oral Glycoprotein Inhibitor

Roche began Phase III clinical trials of Sibrafiban, an oral

Genentech's Year-End Results Show Growth Plan on Track: Earnings Increase Nine Percent on Revenues Exceeding $1 Billion

Full browser ?

CITE

Site: Follow: Share:

Open / Close